Neurodevelopmental and synaptic defects in DNAJC6 parkinsonism, amenable to gene therapy
Brain · 2024
DOI: 10.1093/brain/awae020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, 2024. Verfasst von Lucia Abela und 17 weiteren Autor:innen. Beteiligte Einrichtung: Developmental Neurosciences, Zayed Centre for Research into Rare Disease in Children, UCL Great Ormond Street Institute of Child Health, London, WC1N…. Hauptthemen laut MEDLINE: Genetic Therapy, HSP40 Heat-Shock Proteins, Induced Pluripotent Stem Cells, Parkinsonian Disorders. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Wellcome Trust, NIHR Great Ormond Street Hospital Biomedical Research.
Abstract (Originalsprache)
DNAJC6 encodes auxilin, a co-chaperone protein involved in clathrin-mediated endocytosis (CME) at the presynaptic terminal. Biallelic mutations in DNAJC6 cause a complex, early-onset neurodegenerative disorder characterized by rapidly progressive parkinsonism-dystonia in childhood. The disease is commonly associated with additional neurodevelopmental, neurological and neuropsychiatric features. Currently, there are no disease-modifying treatments for this condition, resulting in significant morbidity and risk of premature mortality. To investigate the underlying disease mechanisms in childhood-onset DNAJC6 parkinsonism, we generated induced pluripotent stem cells (iPSC) from three patients harbouring pathogenic loss-of-function DNAJC6 mutations and subsequently developed a midbrain dopaminergic neuronal model of disease. When compared to age-matched and CRISPR-corrected isogenic controls, the neuronal cell model revealed disease-specific auxilin deficiency as well as disturbance of synaptic vesicle recycling and homeostasis. We also observed neurodevelopmental dysregulation affecting ventral midbrain patterning and neuronal maturation. To explore the feasibility of a viral vector-mediated gene therapy approach, iPSC-derived neuronal cultures were treated with lentiviral DNAJC6 gene transfer, which restored auxilin expression and rescued CME. Our patient-derived neuronal model provides deeper insights into the molecular mechanisms of auxilin deficiency as well as a robust platform for the development of targeted precision therapy approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Developmental Neurosciences, Zayed Centre for Research into Rare Disease in Children, UCL Great Ormond Street Institute of Child Health, London, WC1N 1DZ, UK.
- Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.
- Laboratory of Pharmacology and Brain Pathology, Humanitas Clinical and Research Center, 20089 Milano, Italy.
- Genetic Therapy Accelerator Centre, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
- Department of Neurology, Columbia University Irving Medical Center, New York, NY 10032-3784, USA.
- Department of Pediatrics, Nationwide Children's Hospital, Ohio State University, Columbus, OH 43210, USA.
ORCID-Profile: Kimberley M Reid, John Counsell, Gabriele Lignani
Förderung
- Medical Research Council
- Wellcome Trust
- NIHR Great Ormond Street Hospital Biomedical Research
- Department of Health
- Swiss National Science Foundation
- UK Medical Research Council
- Great Ormond Street Hospital Children's Charity
- Rosetrees Trust
Zitieren
APA
Abela, L., Gianfrancesco, L., Tagliatti, E., Rossignoli, G., Barwick, K., Zourray, C., Reid, K. M., Budinger, D., Ng, J., Counsell, J., Simpson, A., Pearson, T. S., Edvardson, S., Elpeleg, O., Brodsky, F. M., Lignani, G., Barral, S., & Kurian, M. A. (2024). Neurodevelopmental and synaptic defects in DNAJC6 parkinsonism, amenable to gene therapy. Brain. https://doi.org/10.1093/brain/awae020
Vancouver
Abela L, Gianfrancesco L, Tagliatti E, Rossignoli G, Barwick K, Zourray C, et al. Neurodevelopmental and synaptic defects in DNAJC6 parkinsonism, amenable to gene therapy. Brain. 2024. doi:10.1093/brain/awae020
BibTeX
@article{Abela2024,
author = {Abela, Lucia and Gianfrancesco, Lorita and Tagliatti, Erica and Rossignoli, Giada and Barwick, Katy and Zourray, Clara and Reid, Kimberley M and Budinger, Dimitri and Ng, Joanne and Counsell, John and Simpson, Arlo and Pearson, Toni S and Edvardson, Simon and Elpeleg, Orly and Brodsky, Frances M and Lignani, Gabriele and Barral, Serena and Kurian, Manju A},
title = {Neurodevelopmental and synaptic defects in DNAJC6 parkinsonism, amenable to gene therapy},
journal = {Brain},
year = {2024},
doi = {10.1093/brain/awae020}
}
EUVIMED